Loading provider…
Loading provider…
Pulmonary Disease Physician in Fresno, CA
NPI: 1295927911Primary Employer
University Faculty Associates, Inc.
communitymedical.org
HQ Phone
Get MD Vipul's Phone Numberphone_androidMobile
Get MD Vipul's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2004 - 2026

American Board of Internal Medicine
Critical Care Medicine

American Board of Internal Medicine
Pulmonary Disease
University of California (San Diego) Medical Center
Fellowship • Pulmonary Disease and Critical Care Medicine
2005 - 2008
University of California (San Francisco)/Fresno
Residency • Internal Medicine
2002 - 2005
Topiwala National Medical College
Medical School
Until 1997
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99291Critical care delivery critically ill or injured patient, first 30-74 minutes | 33 | 81 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 25 | 31 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 19 | 22 |
| 4 | 94729Measurement of lung diffusing capacity | 13 | 13 |
Authors: Michael Peterson, Karl Vangundy, Michael Peterson, Michael Peterson
Journal: Respir Med
Publication Date: 2014-09-28
Misdiagnosis Among Frequent Exacerbators of Clinically Diagnosed Asthma and COPD in Absence of Confirmation of Airflow Obstruction.
Authors: Sherry Andrews, Michael Peterson
Publication Date: 2015-02-27
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: DRUG: Placebo, BIOLOGICAL: GSK3511294 (Depemokimab)
Lead Sponsor: DBV Technologies
Intervention / Treatment: COMBINATION_PRODUCT: DBV1605
Lead Sponsor: University of Minnesota
Collaborators: United States Department of Defense, University of Alabama at Birmingham
Intervention / Treatment: OTHER: Observational